Sponsor Pipeline

Nanjing Legend Biotech Co. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 1
1
Early Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07331272 A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus… Systemic Lupus Erythematosus (SLE) Recruiting
Early Phase 1
NCT07095075 A Study of LUCAR-DKS1 in Subjects With Relapsed/Refractory Autoimmune Diseases Relapsed/Refractory Autoimmune Diseases Recruiting
Not specified
NCT07100067 LCAR-F33S in Treatment of Relapsed/Refractory Multiple Myeloma Relapsed/Refractory Multiple Myeloma(MM) Recruiting
Disease Areas
Multiple Myeloma (1) Lupus (SLE) (1)
Get alerts when Nanjing Legend Biotech Co.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free